Getinge (PINK:GETI B) said it plans to offer roughly $189 million to acquire Pulsion Medical Systems, a German cardiac monitoring company.
Latest supply deal with Novartis boosts Unilife shares
Pelvic mesh plaintiffs accuse Ethicon of destroying evidence
Plaintiffs in the multi-district pelvic mesh litigation against Johnson & Johnson‘s (NYSE:JNJ) Ethicon subsidiary want a federal judge to impose "severe sanctions" for the company’s alleged mishandling and destruction of 10s of thousands of documents in the case.
St. Jude Medical launches Prodigy neurostim trial for chronic pain
St. Jude Medical (NYSE:STJ) said it launched a clinical trial of its Prodigy neurostimulator to examine the treatment of chronic pain.
Volcano launches $200M stock buyback
Xlumena wraps up $25M Series C round
Xlumena said it closed a $25 million Series C round it plans to use to expand its commercial footprint and win FDA clearance for its Axios stent and delivery system.
Is premium pricing a thing of the past? | MassDevice.com On Call
MASSDEVICE ON CALL — In the pre-Obamacare world, medical device companies were able to price their products at a premium, justified by improvements in quality that were in some cases marginal. But premium pricing "typically becomes an easy target for disruption through product innovation in many other technology industries, especially when the market place is crowded with competitors," writes Mohit Kaushal, a partner at Aberdare Ventures in San Francisco.
MassDevice.com +3 | The top 3 med-tech stories for Dec. 2, 2013
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
UPDATE: HeartWare CEO Doug Godshall details $350M CircuLite buyout
Brazil investigates BD in anti-dumping probe
Becton Dickinson & Co. (NYSE:BDX) said a Brazilian agency today began an anti-dumping probe that’s looking into sales in Brazil of its vacuum tubes used to collect blood.